جست‌وجوی استاد و پژوهشگر

Suzanne Donnellyمشاهده پروفایل

دانشیار

• Medical Education
• Rheumatology
• Clinical Handover
• +۳ مورد دیگر

Associate Professor Suzanne Donnelly serves as Director of Clinical Education and Associate Dean for Programmes & Educational Innovation at University College Dublin's School of Medicine, while maintaining a part-time consultant rheumatology practice at Mater Misericordiae University Hospital specializing in systemic lupus erythematosus and pregnancy management in rheumatic conditions. Education: Medical degree from Trinity College, University of Dublin Specialty clinical training in Ireland and Oxford Her research integrates medical education with clinical practice, pioneering initiatives like the UCD Patient Educator Programme and Care in Medicine curriculum. She investigates empathy development in clinicians, clinical handover protocols, and evidence-based rheumatology care pathways through national collaborations with the Medical Council and National Clinical Effectiveness Committee. Scientific Awards: MD for research on empathy and care in medical education (2016) University Fellowship in Teaching and Academic Development (2014) Dr. Donnelly led Ireland's Medical Council report establishing the Safe Start initiative for new physicians and co-developed national clinical handover guidelines. She serves as external examiner for University of Dundee's medical program and contributes to key textbooks including Medicine At a Glance. She co-leads UCD's Care in Medicine curriculum with Professor Brendan Drumm, represents Ireland on EULAR's Standing Committee on Education, and maintains active roles with Arthritis Ireland, Raynaud’s and Scleroderma Ireland, and Lupus Group Ireland.

Astia Allenzaraمشاهده پروفایل

استادیار

• Autoimmune Diseases
• Rheumatology
• Idiopathic Inflammatory Myopathies
• +۵ مورد دیگر

Astia Allenzara, MD, MSCR is an Assistant Professor of Medicine at the UNC School of Medicine , affiliated with the Division of Rheumatology, Allergy, and Immunology . She focuses on rare autoimmune diseases including idiopathic inflammatory myopathies, scleroderma, and systemic lupus erythematosus. Undergraduate: Smith College Medical School: University of Vermont Residency: Hospital of University of Pennsylvania Fellowship: University of North Carolina Her research investigates comorbidities in autoimmune diseases, particularly cancer and cardiovascular disease development in dermatomyositis patients. She employs retrospective cohort studies and registry-based analyses to identify modifiable risk factors and optimize treatment outcomes. Key publication trends span autoimmune diseases (2023-2025), cardiovascular comorbidities , and obesity-cancer risk relationships , alongside earlier collaborative work in public health (tobacco exposure) and nutrition science (brassica biomarkers). Clinically, she emphasizes longitudinal patient relationships and shared decision-making. Her work integrates rheumatology, epidemiology, and medical education principles to address health equity in autoimmune disease management.

J. Michelle Kahlenbergمشاهده پروفایل

دانشیار

• Autoimmune Diseases
• Rheumatology
• Cutaneous Lupus
• +۵ مورد دیگر

J. Michelle Kahlenberg is a physician-scientist and Associate Professor of Internal Medicine at the University of Michigan School of Medicine . She holds dual appointments in Dermatology and Rheumatology and serves as Vice Chair of Basic and Translational Research in the Department of Internal Medicine. Her clinical focus includes complex lupus management, particularly refractory cutaneous manifestations. Research Interests: Her work bridges innate immunity, interferon biology, and epithelial dysfunction in autoimmune diseases. Key areas are cutaneous lupus pathogenesis, photosensitivity drivers, and skin-systemic disease connections. She employs single-cell multi-omics and murine models to identify therapeutic targets like the IL-36/IFNK axis, inflammasome regulation, and mitochondrial Z-DNA sensing. Interferon Signaling Photosensitivity Mechanisms Keratinocyte Immunology Single-Cell Profiling Translational Autoimmunity Recent Publications emphasize cutaneous immunology, fibrosis, and epithelial-immune crosstalk across lupus, psoriasis, and scleroderma. Articles highlight therapeutic advances (e.g., TYK2 inhibitors) and novel pathogenic networks (e.g., cDC2A-CXCL13+ CD8+ T cell communication). Scientific Awards: 2018 PECASE (Presidential Early Career Award for Scientists and Engineers) 2022 American College of Rheumatology Henry Kunkel Young Investigator Awardee 2023 Henry Kunkel Society admission Inaugural Giles Boles and Dorothy Mulkey Research Chair in Rheumatology Training: She mentors students in the Immunology Training Program since 2013 and accepts new advisees. Her lab focuses on trainee development in translational immunology and dermatology research.

Benjamin Kormanمشاهده پروفایل

دانشیار

• Scleroderma (systemic sclerosis)
• Autoimmune connective tissue diseases
• Fibrosis research
• +۴ مورد دیگر

Benjamin Korman, M.D. is an Associate Professor in the Department of Medicine, Allergy/Immunology and Rheumatology at the University of Rochester School of Medicine and Dentistry. He is a practicing rheumatologist specializing in scleroderma and related autoimmune connective tissue diseases, providing interdisciplinary care for patients with complex manifestations including skin fibrosis, vascular disease, and organ involvement. Dr. Korman's clinical expertise focuses on: Diagnosis and management of scleroderma (systemic sclerosis) Autoimmune connective tissue diseases Interdisciplinary care for skin fibrosis and thickening Vascular disease including Raynaud's phenomenon Gastrointestinal issues related to autoimmune conditions Lung disease including interstitial lung disease and pulmonary hypertension His research program, the Korman Lab, investigates the cellular and molecular mechanisms underlying fibrosis and vascular disease in scleroderma. The lab utilizes experimental models, patient samples, and translational approaches to understand the relationship between adipose cells, blood vessels, and fibroblasts. Current research focuses on: Pulmonary hypertension in scleroderma Skin fibrosis mechanisms The role of TNF signaling in vascular pathology Biomarker discovery for disease severity and progression Novel therapeutic approaches targeting fibrosis pathways Dr. Korman has published extensively on scleroderma, with recent work focusing on TNF-mediated pulmonary hypertension, complement factors as biomarkers, and the role of adipokines in fibrosis. His research has contributed significantly to understanding disease heterogeneity and developing personalized treatment approaches for patients with scleroderma. His scientific contributions include: Development of novel mouse models of scleroderma-associated pulmonary hypertension Identification of biomarkers for scleroderma disease severity Studies on the role of adipose tissue in fibrosis development Investigations into the cellular mechanisms of vascular remodeling Dr. Korman is actively involved in mentoring and training the next generation of rheumatology researchers and clinicians. He leads a multidisciplinary research team investigating the pathogenesis of scleroderma and related conditions, with a focus on translating basic science discoveries into clinical applications for improved patient care.

Flavio Duarte Silvaمشاهده پروفایل

استادیار

• Radiology
• Medical Imaging
• 3D MRI Techniques
• +۶ مورد دیگر

Flavio Duarte Silva is an Assistant Professor of Radiology at UT Southwestern Medical Center, specializing in Musculoskeletal Radiology. He holds an MD and PhD from Universidade Federal de São Paulo (Brazil), with additional fellowships at Université Paris Descartes and the University of Miami. His research focuses on advanced 3D MRI techniques for musculoskeletal applications, including sports medicine, diabetic foot imaging, sarcoma characterization, and image-guided interventions. Education: MD: Universidade Federal de São Paulo Radiology Residency: Universidade Federal de São Paulo Musculoskeletal Fellowship: Universidade Federal de São Paulo Research Fellowships: Université Paris Descartes & University of Miami PhD: Universidade Federal de São Paulo Research Interests: Dr. Silva’s work emphasizes 3D MRI advancements in joint imaging, musculoskeletal tumors, tendon pathology, and clinical translation of imaging innovations. He has pioneered protocols for diagnosing posterior tibialis tendon dysfunction and flat foot deformity. Professional Activities: He serves on the Paulista Society of Radiology, the International Skeletal Society, and the American Roentgen Ray Society. His >45 publications span musculoskeletal imaging, rheumatological disorders, and technical innovations. Labs/Teams: Active in UT Southwestern’s Musculoskeletal Radiology Division, collaborating on MRI-based diagnostic systems (e.g., MSKI-RADS, NS-RADS).

• Pulmonary Medicine
• Critical Care Medicine
• Interstitial Lung Disease
• +۶ مورد دیگر

Alexander Ghincea is a Pulmonary, Critical Care & Sleep Medicine Instructor at Yale School of Medicine. He holds primary affiliation with the Department of Pulmonary, Critical Care & Sleep Medicine and is also part of the Internal Medicine department. Previously, he earned his B.S. in Molecular and Cellular Biology from Regis University, completed medical school at the University of Colorado, and served as Chief Resident in Internal Medicine there. His research focuses on pulmonary fibrosis mechanisms, translational models for interstitial lung diseases, mitochondrial DNA-sensing pathways in systemic sclerosis, adrenoreceptor pharmacology, and comorbidities influencing asthma outcomes. Key collaborators include Wonnie Ryu, Erica Herzog, Huanxing Sun, and Maor Sauler. His work spans experimental mouse models to clinical patient studies, with a recent emphasis on mitigating fibrotic responses through pharmacological interventions (e.g., α1 adrenoreceptor antagonism) and investigating vaccine-related risks in pulmonary diseases. He has published extensively on topics such as CGAS antagonism, NLRP3 inflammasome targeting, and GERD-asthma interactions in obese populations. Though no scientific awards are explicitly listed, his contributions reflect active engagement in high-impact translational research. Advising roles and formal grants are not detailed in the provided texts, but his involvement in collaborative projects suggests active mentorship within research teams. His academic trajectory aligns with the Yale School of Medicine’s emphasis on integrating clinical and basic science research.

• Pulmonary Fibrosis
• Interstitial Lung Disease
• Innate Immunity
• +۴ مورد دیگر

Huanxing Sun is an Assistant Professor in the Department of Pulmonary, Critical Care & Sleep Medicine at Yale School of Medicine. His research focuses on understanding the molecular and cellular mechanisms underlying pulmonary fibrosis, with particular emphasis on mitochondrial DNA signaling, Toll-like receptor pathways, and neuroimmune interactions in lung disease. Dr. Sun holds a PhD from the Chinese Academy of Medical Sciences (2009) and has contributed to over 30 peer-reviewed publications. Primary Appointment: Yale School of Medicine Secondary Affiliation: Interstitial Lung Disease Program Research interests include: - Mechanisms of fibroproliferative responses in idiopathic pulmonary fibrosis and scleroderma-associated ILD - Role of extracellular mitochondrial DNA in driving inflammation and fibrosis - Neuroendocrine regulation of lung fibrosis via adrenergic signaling - Development of translational models to study fibrotic microenvironments Recent work demonstrates that α1 adrenoreceptor antagonism reduces mtDNA-driven fibrosis, while TLR9 inhibition shows promise in mitigating fibroblast activation. Collaborations with Erica Herzog, Wonnie Ryu, and Maor Sauler highlight multidisciplinary approaches to lung disease research. Key contributions include discoveries linking mitochondrial stress to fibrotic progression, and the role of netrin-1/GRB2 signaling in fibrocyte accumulation. Ongoing studies explore biomarkers for disease progression and novel therapeutic targets in fibrotic lung diseases.

Héloïse Cardinalمشاهده پروفایل

دانشیار

• Nephrology
• Transplant Immunology
• Vascular Biology
• +۱ مورد دیگر

Héloïse Cardinal is an Associate Clinical Professor in the Department of Medicine at Université de Montréal, specializing in nephrology and transplantation. She holds the Shire Chair in Nephrology and Renal Transplantation and Regeneration. Education includes medical training at Université de Sherbrooke, nephrology specialization at Université de Montréal, and a PhD in Epidemiology and Biostatistics from McGill University. Research focuses on: Vascular injury biomarkers in transplantation Immune mechanisms of graft rejection Anti-LG3 antibodies in transplant outcomes Her research program characterizes novel biomarkers for predicting renal transplant complications and investigates vascular pathology in graft rejection. Recent work defines scleromyositis as a distinct clinical entity (2023) and establishes autoantibody-based subclassification of scleroderma-related myopathy (2022). Research support includes funding from: Fonds de recherche du Québec – santé Kidney Foundation of Canada CHUM Research Centre

Fatma Dedeogluمشاهده پروفایل

دانشیار

• Autoinflammatory Diseases
• Periodic Fever Syndromes
• Juvenile Localized Scleroderma
• +۴ مورد دیگر

Fatma Dedeoglu, MD is an Attending Physician in the Rheumatology Program at Boston Children's Hospital and an Associate Professor of Pediatrics at Harvard Medical School. With over 35 years of medical experience since graduating from Istanbul School of Medicine in 1986, she has established herself as a leading expert in pediatric rheumatology specializing in autoinflammatory diseases. Education: Istanbul School of Medicine (MD, 1986) Monmouth Medical Center (Residency, 1999) Boston Children's Hospital (Fellowship, 2003) Dr. Dedeoglu's research focuses on autoinflammatory diseases, particularly periodic fever syndromes and juvenile localized scleroderma. Her work spans multiple areas including the development of classification criteria for pediatric chronic nonbacterial osteomyelitis, studying sex differences in juvenile idiopathic arthritis, and investigating novel treatments like anifrolumab for dermatomyositis. She has made significant contributions to understanding the immunological mechanisms behind conditions such as macrophage activation syndrome and Kawasaki disease. Analysis of her recent publications reveals strong emphasis on quantitative disease assessment methods, particularly 3D imaging for craniofacial morphea, and biomarker discovery for differential diagnosis of pediatric inflammatory conditions. Her research bridges clinical practice with immunological investigation, with particular attention to interferon pathways and cytokine signatures in autoinflammatory disorders. As a board-certified specialist in pediatric rheumatology by the American Board of Pediatrics, Dr. Dedeoglu provides clinical care across multiple Boston Children's Hospital locations including Boston, Lexington, and Waltham. She is fluent in both English and Turkish, allowing her to serve a diverse patient population. Her clinical practice focuses on juvenile arthritis and vasculitis, with special expertise in complex autoinflammatory conditions affecting children.

• Immunobiology
• Innate and Adaptive Immunity
• Autoimmunity
• +۷ مورد دیگر

Richard Flavell is a Sterling Professor of Immunobiology at Yale School of Medicine and an Investigator at the Howard Hughes Medical Institute. His research focuses on innate and adaptive immunity, T cell regulation, apoptosis, and autoimmune disease mechanisms using transgenic and gene-targeted mice. Education: B.Sc. (Honors) in Biochemistry, University of Hull (1967) Ph.D. in Biochemistry, University of Hull (1970) Postdoctoral Fellow, University of Amsterdam (1972) and University of Zurich (1973) His work explores Toll-like receptors, NOD-like receptors, TGF-beta signaling, and inflammasomes in autoimmunity, infection, and cancer. He has developed humanized mouse models to study immune responses in diseases like melanoma and scleroderma. Recent publications highlight his contributions to understanding cross-chromosomal gene regulation, metabolic immune switches, and adjuvant mechanisms. His lab's research bridges immunology, microbiome studies, and computational biology. Scientific Honors: Vilcek Prize in Biomedical Science (2013) William B. Coley Award (2012) Fellow of the Royal Society Member, National Academy of Sciences Member, National Academy of Medicine Flavell's team has secured grants including a $575,000 PolyBio Research Foundation award for Long COVID studies. The Flavell Lab at Yale investigates immune system integration with environmental and microbial factors.

• Immunology
• Autoimmune diseases
• Genomics
• +۴ مورد دیگر

Professor Tony Kenna is an immunologist at Queensland University of Technology (QUT), leading research in autoimmune diseases like ankylosing spondylitis (AS) and scleroderma. He holds a PhD in Pharmacology from University College Dublin and is based in the School of Biomedical Sciences within QUT's Faculty of Health . His work integrates genomics, microbiome studies, and cellular immunology to identify therapeutic targets for immune-mediated diseases. He collaborates with the Centre for Immunology and Infection Control and Centre for Microbiome Research at QUT. Teaching focuses on undergraduate immunology, emphasizing problem-based learning. His editorial roles include journals like Clinical and Translational Immunology and Discovery Immunology . Professional memberships include the Australia and New Zealand Society for Immunology and the Australian Society for Medical Research. Research interests span genetic drivers of AS/scleroderma, microbiome-immune interactions, and translational therapies. Recent work highlights T-cell dysregulation in autoimmune conditions and biomarkers for disease progression. His lab explores therapeutic strategies like CAR-T cells and TCR-engineered regulatory T-cells for autoimmune diseases. Publications emphasize genomics-driven discoveries (e.g., HLA-B27 interactions, Runx3 deficiency in SKG mice), microbiome roles in AS pathogenesis, and long-term post-COVID-19 immunopathology. Collaborations bridge clinical and basic science to advance understanding of immune system dysregulation.

• Lymphatic Biology
• Immunology
• Vascular Biology
• +۵ مورد دیگر

Adri Chakraborty is a Research Assistant Professor at the Boston University Chobanian & Avedisian School of Medicine, affiliated with the Arthritis & Autoimmune Diseases Research Center. He is also a Senior Scientist at OdinTX, focusing on immuno-oncolytics and cancer therapeutics. His expertise spans lymphatic biology, pulmonary fibrosis, and metabolic disorders. Education: PhD from University of the Sciences in Philadelphia, MS and BS from Bangalore University. Research interests include lymphatic vessel biology, ERG gene regulation in fibrosis, VEGF-D signaling in adipose tissue, and inflammation mechanisms. His work bridges basic science and translational medicine, particularly in lymphatic dysfunction and cancer therapeutics. Publications highlight studies on ERG deficiency's role in pulmonary fibrosis, VEGF-D-driven lymphangiogenesis in obesity, and lipedema pathophysiology. Recent work emphasizes lymphatic-vascular interactions in wound healing and neurogenic inflammation. Awards: 2018 Keystone Symposium Award, Pappenheimer Postdoctoral Award, and Lipedema Foundation Grant. Grants: PI of Scleroderma Foundation-funded project (2022–2025) on lymphatic Erg deficiency in pulmonary fibrosis. Collaborations include work with OdinTX on immuno-oncology and extensive co-authorships in lymphatic research (e.g., with Trojanowska, Rutkowski, and Ligresti).

• Diabetes/Neuropathy
• Microvascular Complications
• Atherosclerosis
• +۵ مورد دیگر

Maria Jeziorska is a Senior Lecturer in Molecular Pathology at the University of Manchester, affiliated with the School of Medical Sciences within the Faculty of Biology, Medicine and Health. Her research focuses on diabetic neuropathy, atherosclerosis, scleroderma, tumor invasion mechanisms, and paleopathology. She obtained her MD and PhD from the Medical Academy in Warsaw, Poland, and has conducted research at Manchester for over 25 years. Education: Doctor of Philosophy (Medical Academy, 1986) Doctor of Medicine (Medical Academy, 1986) Research Interests: Diabetes complications: Microvascular pathogenesis, neuropathy diagnostics Scleroderma: Microvascular changes and neuropathy Soft tissue sarcomas: Tumor progression and metastasis Atherosclerosis: Cytokine roles in calcification Paleopathology: Antigen retrieval in mummified tissues Current Projects: Assessment of diabetic neuropathy via skin biopsies and corneal confocal microscopy Effects of treatment on small fiber neuropathy in sarcoidosis Adipokine expression post-bariatric surgery Hypoxia in diabetic heart tissues Antigen recovery methods for mummified tissues Grants & Collaboration: Co-Investigator on a multinational project evaluating corneal confocal microscopy for diabetic neuropathy diagnosis (2015–2018)

Ariane Herrickمشاهده پروفایل

استاد

• Rheumatology
• Systemic Sclerosis
• Raynaud’s Phenomenon
• +۳ مورد دیگر

Professor Ariane Herrick is a Professor of Rheumatology at the University of Manchester, based in the Division of Musculoskeletal & Dermatological Sciences. She also serves as an Honorary Consultant Rheumatologist at Salford Royal NHS Foundation Trust. Her career spans over three decades with key appointments since 1993 (Consultant) and 2011 (Professor). Education: She earned her medical degree from the University of Aberdeen, followed by general medical training at Western Infirmary in Glasgow and specialized rheumatology training in Salford. Her professional memberships include the British Society for Rheumatology and the British Microcirculation Society. Research Interests: Her work focuses on systemic sclerosis-spectrum disorders and Raynaud’s phenomenon. She investigates vascular abnormalities using imaging techniques like nailfold capillaroscopy and explores novel treatments such as chelation therapies and low-level light therapy for calcinosis and digital ulcers. She leads clinical trials and collaborates with international groups like the SCTC and EUSTAR to advance diagnostic and therapeutic standards. Scientific Awards: A notable honor is her Fellowship of the Royal Society of Medicine (FRSM). Advising & Grants: As Principal Investigator, she oversees trials evaluating drug efficacy and imaging biomarkers. She has supervised 3 academic works, though specific student names are not disclosed. Her grants support innovations in microvascular assessment and patient-centered outcome measures. Labs/Teams: She collaborates with the UK Systemic Sclerosis Study Group, the Scleroderma Clinical Trials Consortium (SCTC), and the European Scleroderma Trials and Research Group (EUSTAR), contributing to large-scale observational studies like the European Scleroderma Observational Study (ESOS). Her research integrates clinical, imaging, and molecular approaches to address unmet needs in SSc management.

Ram Raj Singhمشاهده پروفایل

استاد

• Autoimmunity
• Rheumatology
• Immunology
• +۶ مورد دیگر

Ram Raj Singh is a Professor of Medicine and Pathology and Laboratory Medicine at the University of California Los Angeles (UCLA), where he maintains a dual appointment in the School of Medicine. His research spans multiple areas of immunology and autoimmune diseases, with particular focus on systemic sclerosis and lupus. Dr. Singh's research interests center on the immunological mechanisms underlying autoimmune diseases, particularly focusing on T-cell and B-cell biology in systemic sclerosis and lupus. His work explores the pathogenesis of autoimmune disorders, examining how innate and adaptive immune responses contribute to tissue damage and disease progression. His research has significant implications for understanding mortality patterns in autoimmune diseases and developing targeted therapies. Analysis of Dr. Singh's publication record reveals a strong focus on autoimmune disease epidemiology, particularly examining mortality trends in systemic sclerosis and lupus across different demographic groups. His research demonstrates expertise in both clinical and basic immunology, with publications spanning molecular mechanisms of disease to population-level health outcomes. A consistent theme throughout his work is the examination of how immune cell subsets (particularly T cells, B cells, and dendritic cells) contribute to autoimmune pathology. Dr. Singh has served as Principal Investigator on multiple NIH-funded research projects, including R01, R21, and T32 grants focused on autoimmune diseases. His research portfolio includes investigations into the pathogenesis of lupus dermatitis, gender bias in lupus, and the role of innate B1 B cells in lung hemorrhage. He has contributed significantly to understanding the immunological basis of autoimmune diseases and their clinical manifestations.